Literature DB >> 15797784

Microbiological assay for the determination of meropenem in pharmaceutical dosage form.

Andreas S L Mendez1, Vanessa Weisheimer, Tércio P Oppe, Martin Steppe, Elfrides E S Schapoval.   

Abstract

Meropenem is a highly active carbapenem antibiotic used in the treatment of a wide range of serious infections. The present work reports a microbiological assay, applying the cylinder-plate method, for the determination of meropenem in powder for injection. The validation method yielded good results and included linearity, precision, accuracy and specificity. The assay is based on the inhibitory effect of meropenem upon the strain of Micrococcus luteus ATCC 9341 used as the test microorganism. The results of assay were treated statistically by analysis of variance (ANOVA) and were found to be linear (r=0.9999) in the range of 1.5-6.0 microg ml(-1), precise (intra-assay: R.S.D.=0.29; inter-assay: R.S.D.=0.94) and accurate. A preliminary stability study of meropenem was performed to show that the microbiological assay is specific for the determination of meropenem in the presence of its degradation products. The degraded samples were also analysed by the HPLC method. The proposed method allows the quantitation of meropenem in pharmaceutical dosage form and can be used for the drug analysis in routine quality control.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15797784     DOI: 10.1016/j.jpba.2004.11.030

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Comparative in vitro study of the antimicrobial activities of different commercial antibiotic products for intravenous administration.

Authors:  Edelberto Silva; Jorge A Díaz; María J Arias; Angela P Hernández; Andrés de la Torre
Journal:  BMC Clin Pharmacol       Date:  2010-01-29

2.  Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: the case of meropenem.

Authors:  M Agudelo; C A Rodriguez; C A Pelaez; O Vesga
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

3.  Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics.

Authors:  Andres F Zuluaga; Maria Agudelo; Carlos A Rodriguez; Omar Vesga
Journal:  BMC Clin Pharmacol       Date:  2009-01-16

4.  Comparison of microbiological and high-performance liquid chromatographic methods for determination of clarithromycin levels in plasma.

Authors:  Farzaneh Lotfipour; Hadi Valizadeh; Somayeh Hallaj-Nezhadi; Morteza Milani; Parvin Zakeri-Milani
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.